Citeline：2024年JPM医疗健康大会展望摘要报告（英文版）（31页）.pdf

1、ReportOutlook 2024 Preview ReportSponsored by2December 2023 Copyright 2023 Pharma Intelligence UK Limited,a Citeline company(Unauthorized photocopying prohibited)ForewordBiotech Innovation Drives Industry Changes In HealthcareForeword by Chris Smyth,President,ICON Biotech Numerous advancements have

2、impacted clinical development over the past year,including new modalities,breakthrough technologies,digital transformation,and novel clinical trial designs.We continue to see immense growth potential in the biotech industry with never-before-seen CRISPR technology and robust cell and gene therapies

3、progressing through late-stage clinical trials;however,we also see challenges with increased market competition and lack of funding for more complex treatments.In order to keep pace with innovation,it is becoming imperative for life sciences companies to make the necessary strategic pivots that will

4、 get products to the finish line more efficiently.As the worlds largest clinical research organization(CRO),ICON provides support and expertise to help companies mitigate the costs and risks associated with clinical development.We offer flexible partnership models that inform decision-making through

5、 extensive data resources and integrated clinical capabilities.From helping an emerging biotech meet its milestones,to assisting with the global launch of a first-in-class drug,our healthcare intelligence is what differentiates us from other CROs.Regulation,manufacturing,and other parts of clinical

6、development are growing more difficult to juggle as complexity rises,especially for smaller biotechs.With 8,000 experts working in our dedicated biotech division,ICON Biotech,we are dedicated to meeting the individualized needs of life sciences organizations.We are eager to explore the insights shar